Rothschild Asset Management Inc. raised its position in LHC Group (NASDAQ:LHCG) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 575,153 shares of the health services provider’s stock after purchasing an additional 27,613 shares during the quarter. Rothschild Asset Management Inc. owned 3.15% of LHC Group worth $40,790,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. BlackRock Inc. increased its position in shares of LHC Group by 18.1% during the second quarter. BlackRock Inc. now owns 2,325,510 shares of the health services provider’s stock worth $157,879,000 after acquiring an additional 356,014 shares during the period. Vanguard Group Inc. increased its position in shares of LHC Group by 2.2% during the second quarter. Vanguard Group Inc. now owns 1,464,057 shares of the health services provider’s stock worth $99,395,000 after acquiring an additional 32,049 shares during the period. Dimensional Fund Advisors LP increased its position in shares of LHC Group by 1.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,275,663 shares of the health services provider’s stock worth $86,604,000 after acquiring an additional 13,347 shares during the period. Ameriprise Financial Inc. increased its position in shares of LHC Group by 6.5% during the third quarter. Ameriprise Financial Inc. now owns 616,829 shares of the health services provider’s stock worth $43,747,000 after acquiring an additional 37,873 shares during the period. Finally, State Street Corp increased its position in shares of LHC Group by 7.5% during the second quarter. State Street Corp now owns 420,839 shares of the health services provider’s stock worth $28,568,000 after acquiring an additional 29,464 shares during the period. 82.63% of the stock is currently owned by institutional investors.
A number of analysts have recently weighed in on the company. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price objective on shares of LHC Group in a research report on Wednesday, September 6th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 target price for the company in a research note on Saturday, August 5th. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Oppenheimer Holdings, Inc. boosted their target price on shares of LHC Group from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $68.00 target price on shares of LHC Group in a research note on Friday, August 4th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $76.90.
TRADEMARK VIOLATION WARNING: This report was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://sportsperspectives.com/2017/11/21/lhc-group-lhcg-shares-bought-by-rothschild-asset-management-inc.html.
LHC Group (LHCG) traded down $1.13 during midday trading on Tuesday, reaching $66.52. 236,000 shares of the company’s stock traded hands, compared to its average volume of 141,490. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a one year low of $41.66 and a one year high of $76.14. The firm has a market capitalization of $1,220.00, a P/E ratio of 29.03, a PEG ratio of 2.01 and a beta of 0.70.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The company had revenue of $272.90 million during the quarter, compared to the consensus estimate of $265.35 million. During the same quarter in the prior year, the firm posted $0.54 earnings per share. LHC Group’s revenue for the quarter was up 18.2% on a year-over-year basis. sell-side analysts anticipate that LHC Group will post 2.4 earnings per share for the current year.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 14.80% of the stock is currently owned by corporate insiders.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.